Literature DB >> 27709331

How to Diagnose and Treat Functional Chest Pain.

Jose M Remes-Troche1,2,3.   

Abstract

OPINION STATEMENT: Chest pain that is not explained by reflux disease or cardiac, musculoskeletal, mucosal, or motor esophageal abnormalities is classified as functional chest pain (FCP). Although several mechanisms are involved, esophageal hypersensitivity plays a major role and it could be considered a biomarker for FCP. Psychologic comorbidity such as anxiety, neuroticism, depression, and somatization is common. When the diagnosis of FCP is suspected, patients should undergo evaluation with esophageal motility testing, endoscopy, 24-h esophageal pH monitoring, and in some cases, sensory tests. Once the diagnosis of FCP has been established, treatment options rely on controlling patients' symptoms. Medical treatment has focused predominantly on medications that target pain, such as antidepressants and other pain neuromodulators. Non-pharmacologic interventions with complementary behavioral treatments, such as cognitive behavioral therapy, biofeedback, and hypnosis, have recently been recognized as useful in FCP patients. The latest findings on the evaluation and treatment of FCP are outlined herein.

Entities:  

Keywords:  Antidepressants; Esophagus; Functional chest pain; Hypersensitivity; Pain modulators

Year:  2016        PMID: 27709331     DOI: 10.1007/s11938-016-0106-y

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  82 in total

1.  Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial.

Authors:  Hyuk Lee; Jeong Hwan Kim; Byung-Hoon Min; Jun Haeng Lee; Hee Jung Son; Jae J Kim; Jong Chul Rhee; Young Ju Suh; Seonwoo Kim; Poong-Lyul Rhee
Journal:  Am J Gastroenterol       Date:  2010-03-23       Impact factor: 10.864

2.  Globus pharyngeus: effectiveness of treatment with proton pump inhibitors and gabapentin.

Authors:  Suzanne Kirch; Ryan Gegg; Michael M Johns; Adam D Rubin
Journal:  Ann Otol Rhinol Laryngol       Date:  2013-08       Impact factor: 1.547

3.  Unexplained chest pain: the hypersensitive, hyperreactive, and poorly compliant esophagus.

Authors:  S S Rao; H Gregersen; B Hayek; R W Summers; J Christensen
Journal:  Ann Intern Med       Date:  1996-06-01       Impact factor: 25.391

4.  Diagnostic yield of 24-hour esophageal manometry in non-cardiac chest pain.

Authors:  M Barret; T V K Herregods; J M Oors; A J P M Smout; A J Bredenoord
Journal:  Neurogastroenterol Motil       Date:  2016-03-27       Impact factor: 3.598

5.  Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study.

Authors:  Nikos Viazis; Anastasia Keyoglou; Alexandros K Kanellopoulos; George Karamanolis; John Vlachogiannakos; Konstantinos Triantafyllou; Spiros D Ladas; Dimitrios G Karamanolis
Journal:  Am J Gastroenterol       Date:  2011-05-31       Impact factor: 10.864

Review 6.  The hypersensitive esophagus: pathophysiology, evaluation, and treatment options.

Authors:  Jose M Remes-Troche
Journal:  Curr Gastroenterol Rep       Date:  2010-10

7.  Wireless pH monitoring in patients with non-cardiac chest pain.

Authors:  Chandra Prakash; Ray E Clouse
Journal:  Am J Gastroenterol       Date:  2006-03       Impact factor: 10.864

8.  Functional luminal imaging probe topography: an improved method for characterizing esophageal distensibility in eosinophilic esophagitis.

Authors:  Zhiyue Lin; Peter J Kahrilas; Yinglian Xiao; Frédéric Nicodème; Nirmala Gonsalves; Ikuo Hirano; John E Pandolfino
Journal:  Therap Adv Gastroenterol       Date:  2013-03       Impact factor: 4.409

Review 9.  Visceral hypersensitivity in noncardiac chest pain.

Authors:  Anthony J Lembo
Journal:  Gastroenterol Clin North Am       Date:  2004-03       Impact factor: 3.806

10.  Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD.

Authors:  K C Trimble; A Pryde; R C Heading
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.